Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20

Journal of Molecular Biology

Volumn 421, Issue 2-3, 2012, Pages 282-295

  Cao, Ping ^a   Tu, Ling Hsien ^a   Abedini, Andisheh ^b   Levsh, Olesya ^a   Akter, Rehana ^a   Patsalo, Vadim ^c   Schmidt, Ann Marie ^b   Raleigh, Daniel P ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Stony Brook University   (United States)

Author keywords

amylin; amyloid inhibitor; islet amyloid polypeptide; missense mutation; type 2 diabetes

Indexed keywords

AMYLIN; AMYLOID; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING ASSAY; CIRCULAR DICHROISM; CONTROLLED STUDY; HUMAN; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE;

RATTUS;

EID: 84862277598     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.12.032     Document Type: Article

References (71)

1. Sipe J.D. Amyloidosis Crit. Rev. Clin. Lab. Sci. 31 1994 325 354
2. Selkoe D.J. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases Nat. Cell Biol. 6 2004 1054 1061
3. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75 2006 333 366
4. Lansbury P.T., and Lashuel H.A. A century-old debate on protein aggregation and neurodegeneration enters the clinic Nature 443 2006 774 779
5. Westermark P., Wernstedt C., Wilander E., Hayden D.W., Obrien T.D., and Johnson K.H. Amyloid fibrils in human insulinoma and islets of langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells Proc. Natl Acad. Sci. USA 84 1987 3881 3885
6. Cooper G.J., Willis A.C., Clark A., Turner R.C., Sim R.B., and Reid K.B. Purification and characterization of a peptide from amyloid-rich pancreases of type-2 diabetic patients Proc. Natl Acad. Sci. USA 84 1987 8628 8632
7. Kahn S.E., Andrikopoulos S., and Verchere C.B. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes Diabetes 48 1999 241 253
8. Clark A., Cooper G.J., Lewis C.E., Morris J.F., Willis A.C., Reid K.B., and Turner R.C. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes Lancet 2 1987 231 234
9. Hull R.L., Westermark G.T., Westermark P., and Kahn S.E. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes J. Clin. Endocrinol. Metab. 89 2004 3629 3643
10. Marzban L., Park K., and Verchere C.B. Islet amyloid polypeptide and type 2 diabetes Exp. Gerontol. 38 2003 347 351
11. Westermark P., Wernstedt C., Wilander E., and Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas Biochem. Biophys. Res. Commun. 140 1986 827 831
12. Jaikaran E.T., Higham C.E., Serpell L.C., Zurdo J., Gross M., Clark A., and Fraser P.E. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis J. Mol. Biol. 308 2001 515 525
13. Cooper G.J. Amylin compared with calcitonin-gene-related peptide - structure, biology, and relevance to metabolic disease Endocr. Rev. 15 1994 163 201
14. Hutton J.C. The insulin secretory granule Diabetologia 32 1989 271 281
15. Nishi M., Sanke T., Nagamatsu S., Bell G.I., and Steiner D.F. Islet amyloid polypeptide - a new beta-cell secretory product related to islet amyloid deposits J. Biol. Chem. 265 1990 4173 4176
16. Lorenzo A., Razzaboni B., Weir G.C., and Yankner B.A. Pancreatic-islet cell toxicity of amylin associated with type-2 diabetes-mellitus Nature 368 1994 756 760
17. Clark A., Wells C.A., Buley I.D., Cruickshank J.K., Vanhegan R.I., and Matthews D.R. Islet amyloid, increased alpha-cells, reduced beta-cells and exocrine fibrosis - quantitative changes in the pancreas in type-2 diabetes Diabetes Res. 9 1988 151 159
18. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., and Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 2003 102 110
19. Hayden M.R., Karuparthi P.R., Manrique C.M., Lastra G., Habibi J., and Sowers J.R. Longitudinal ultrastructure study of islet amyloid in the HIP rat model of type 2 diabetes mellitus Exp. Biol. Med. 232 2007 772 779
20. Rocken C., Linke R.P., and Saeger W. Immunohistology of islet amyloid polypeptide in diabetes mellitus: semiquantitative studies in a postmortem series Virchows Arch. A 421 1992 339 344
21. Westermark P., Andersson A., and Westermark G.T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus Physiol. Rev. 91 2011 795 826
22. Abedini A., and Raleigh D.P. Islet amyloid polypeptide, in protein misfolding diseases: current and emerging principles and therapies M. Ramirez-Alvarado, J.W. Kelly, C.M. Dobson, Islet Amyloid Polypeptide 2010 John Wiley & Sons, Inc. New York, NY 517 541
23. Westermark G.T., Westermark P., Berne C., Korsgren O., and Nordic Network Widespread amyloid deposition in transplanted human pancreatic islets New Engl. J. Med. 359 2008 977 979
24. Westermark G.T., Westermark P., Nordin A., Tornelius E., and Andersson A. Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice Upsala J. Med. Sci. 108 2003 193 203
25. Udayasankar J., Kodama K., Hull R.L., Zraika S., Aston-Mourney K., and Subramanian S.L. Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets Diabetologia 52 2009 145 153
26. Potter K.J., Abedini A., Marek P., Klimek A.M., Butterworth S., and Driscoll M. Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts Proc. Natl Acad. Sci. USA 107 2010 4305 4310
27. Hammarstrom P., Wiseman R.L., Powers E.T., and Kelly J.W. Prevention of transthyretin amyloid disease by changing protein misfolding energetics Science 299 2003 713 716
28. Levy E., Carman M.D., Fernandezmadrid I.J., Power M.D., Lieberburg I., and Vanduinen S.G. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type Science 248 1990 1124 1126
29. Hardy J. Amyloid, the presenilins and Alzheimer's disease Trends Neurosci. 20 1997 154 159
30. Sakagashira S., Sanke T., Hanabusa T., Shimomura H., Ohagi S., and Kumagaye K.Y. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients Diabetes 45 1996 1279 1281
31. Morita S., Sakagashira S., Ueyama M., Shimajiri Y., Furuta M., and Sanke T. Progressive deterioration of insulin secretion in Japanese type 2 diabetic patients in comparison with those who carry the S20G mutation of the islet amyloid polypeptide gene: a long-term follow-up study J. Diabetes Invest. 2 2011 287 292
32. Lee S.C., Hashim Y., Li J.K., Ko G.T., Critchley J.A., Cockram C.S., and Chan J.C. The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels Clin. Endocrinol. 54 2001 541 546
33. Sakagashira S., Hiddinga H.J., Tateishi K., Sanke T., Hanabusa T., Nanjo K., and Eberhardt N.L. S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin Am. J. Pathol. 157 2000 2101 2109
34. Ma Z., Westermark G.T., Sakagashira S., Sanke T., Gustavsson A., and Sakamoto H. Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide Amyloid 8 2001 242 249
35. Luca S., Yau W.M., Leapman R., and Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR Biochemistry 46 2007 13505 13522
36. Wiltzius J.J., Sievers S.A., Sawaya M.R., Cascio D., Popov D., Riekel C., and Eisenberg D. Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin) Protein Sci. 17 2008 1467 1474
37. Wang L., Middleton C.T., Singh S., Reddy A.S., Woys A.M., and Strasfeld D.B. 2DIR spectroscopy of human amylin fibrils reflects stable β-sheet structure J. Am. Chem. Soc. 133 2011 16062 16071
38. Levine H. Thioflavine-T interaction with amyloid beta-sheet structures Amyloid 2 1995 1 6
39. O'Nuallain B., Williams A.D., Westermark P., and Wetzel R. Seeding specificity in amyloid growth induced by heterologous fibrils J. Biol. Chem. 279 2004 17490 17499
40. Krebs M.R., Morozova-Roche L.A., Daniel K., Robinson C.V., and Dobson C.M. Observation of sequence specificity in the seeding of protein amyloid fibrils Protein Sci. 13 2004 1933 1938
41. Koo B.W., Hebda J.A., and Miranker A.D. Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide Protein Eng. Des. Sel. 21 2008 147 154
42. Wiltzius J.J., Sievers S.A., Sawaya M.R., and Eisenberg D. Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process Protein Sci. 18 2009 1521 1530
43. Abedini A., and Raleigh D.P. A role for helical intermediates in amyloid formation by natively unfolded polypeptides? Phys. Biol. 6 2009 015005
44. Abedini A., and Raleigh D.P. A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides Protein Eng. Des. Sel. 22 2009 453 459
45. Williamson J.A., and Miranker A.D. Direct detection of transient alpha-helical states in islet amyloid polypeptide Protein Sci. 16 2007 110 117
46. Williamson J.A., Loria J.P., and Miranker A.D. Helix stabilization precedes aqueous and bilayer-catalyzed fiber formation in islet amyloid polypeptide J. Mol. Biol. 393 2009 383 396
47. Cao P., Meng F., Abedini A., and Raleigh D.P. The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors Biochemistry 49 2010 872 881
48. Meng F.L., Abedini A., and Raleigh D.P. Combination of kinetically selected inhibitors in trans leads to highly effective inhibition of amyloid formation J. Am. Chem. Soc. 132 2010 14340 14342
49. Abedini A., Meng F.L., and Raleigh D.P. A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor J. Am. Chem. Soc. 129 2007 11300 11301
50. Marek P., Gupta R., and Raleigh D.P. The fluorescent amino acid p-cyanophenylalanine provides an intrinsic probe of amyloid formation ChemBioChem 9 2008 1372 1374
51. Marek P., Mukherjee S., Zanni M.T., and Raleigh D.P. Residue-specific, real-time characterization of lag-phase species and fibril growth during amyloid formation: a combined fluorescence and IR study of p-cyanophenylalanine analogs of islet amyloid polypeptide J. Mol. Biol. 400 2010 878 888
52. Taskent-Sezgin H., Chung J., Patsalo V., Miyake-Stoner S.J., Miller A.M., and Brewer S.H. Interpretation of p-cyanophenylalanine fluorescence in proteins in terms of solvent exposure and contribution of side-chain quenchers: a combined fluorescence, IR and molecular dynamics study Biochemistry 48 2009 9040 9046
53. Taskent-Sezgin H., Marek P., Thomas R., Goldberg D., Chung J., Carrico I., and Raleigh D.P. Modulation of p-cyanophenylalanine fluorescence by amino acid side chains and rational design of fluorescence probes of alpha-helix formation Biochemistry 49 2010 6290 6295
54. Tucker M.J., Oyola R., and Gai F. A novel fluorescent probe for protein binding and folding studies: p-cyano-phenylalanine Biopolymers 83 2006 571 576
55. Padrick S.B., and Miranker A.D. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis Biochemistry 41 2002 4694 4703
56. Abedini A., and Raleigh D.P. The role of His-18 in amyloid formation by human islet amyloid polypeptide Biochemistry 44 2005 16284 16291
57. Cao P., and Raleigh D.P. Ester to amide switch peptides provide a simple method for preparing monomeric islet amyloid polypeptide under physiologically relevant conditions and facilitate investigations of amyloid formation J. Am. Chem. Soc. 132 2010 4052 4053
58. Higham C.E., Jaikaran E.T., Fraser P.E., Gross M., and Clark A. Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils FEBS Lett. 470 2000 55 60
59. Konarkowska B., Aitken J.F., Kistler J., Zhang S.P., and Cooper G.J. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells FEBS J. 273 2006 3614 3624
60. Collins S.R., Douglass A., Vale R.D., and Weissman J.S. Mechanism of prion propagation: amyloid growth occurs by monomer addition PLoS Biol. 2 2004 1582 1590
61. Xue W.F., Homans S.W., and Radford S.E. Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly Proc. Natl Acad. Sci. USA 105 2008 8926 8931
62. Knowles T.P., Waudby C.A., Devlin G.L., Cohen S.I., Aguzzi A., and Vendruscolo M. An analytical solution to the kinetics of breakable filament assembly Science 326 2009 1533 1537
63. Bishop M.F., and Ferrone F.A. Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway Biophys. J. 46 1984 631 644
64. Parrini C., Taddei N., Ramazzotti M., Degl'lnnocenti D., Ramponi G., Dobson C.M., and Chiti F. Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation Structure 13 2005 1143 1151
65. Williams A.D., Shivaprasad S., and Wetzel R. Alanine scanning mutagenesis of A beta(1-40) amyloid fibril stability J. Mol. Biol. 357 2006 1283 1294
66. Anil B., Song B.B., Tang Y.F., and Raleigh D.P. Exploiting the right side of the ramachandran plot: substitution of glycines by d-alanine can significantly increase protein stability J. Am. Chem. Soc. 126 2004 13194 13195
67. Xu W.X., Jiang P., and Mu Y.G. Conformation preorganization: effects of S20G mutation on the structure of human islet amyloid polypeptide segment J. Phys. Chem. B 113 2009 7308 7314
68. Liu G., Prabhakar A., Aucoin D., Simon M., Sparks S., and Robbins K.J. Mechanistic studies of peptide self-assembly: transient alpha-helices to stable beta-sheets J. Am. Chem. Soc. 132 2010 18223 18232
69. Abedini A., Singh G., and Raleigh D.P. Recovery and purification of highly aggregation-prone disulfide-containing peptides: application to islet amyloid polypeptide Anal. Biochem. 351 2006 181 186
70. Nilsson M.R., and Raleigh D.P. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin J. Mol. Biol. 294 1999 1375 1385
71. Nilsson M.R., Driscoll M., and Raleigh D.P. Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: implications for the study of amyloid formation Protein Sci. 11 2002 342 349